alloxan has been researched along with betadex in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abakumov, V; Belica-Pacha, S; Belonovskaya, E; Buko, V; Kranc, R; Lukivskaya, O; Naruta, E; Palecz, B; Zavodnik, I | 1 |
1 other study(ies) available for alloxan and betadex
| Article | Year |
|---|---|
Cytoprotection of pancreatic β-cells and hypoglycemic effect of 2-hydroxypropyl-β-cyclodextrin: sertraline complex in alloxan-induced diabetic rats.
Topics: 2-Hydroxypropyl-beta-cyclodextrin; Alloxan; Animals; beta-Cyclodextrins; Diabetes Mellitus, Experimental; Female; Hypoglycemic Agents; Insulin-Secreting Cells; Rats; Rats, Wistar; Sertraline | 2016 |